Abiopharma

LeBlanc Dorian Paul 🟢 acquired 3 shares (1 derivative) of LEMAITRE VASCULAR INC (LMAT) Transaction Date: Sep 04, 2025 | Filing ID: 028582

Johnson & Johnson - Johnson & Johnson Elects John Morikis, Retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, to its Board of Directors

Johnson & Johnson Elects John Morikis, Retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, to its Board of Directors

Director Pellegrino Joseph P JR 🟢 acquired 19 shares (7 derivative) of LEMAITRE VASCULAR INC (LMAT) Transaction Date: Sep 04, 2025 | Filing ID: 028581

Director Roberts David B 🟢 acquired 19 shares (8 derivative) of LEMAITRE VASCULAR INC (LMAT) Transaction Date: Sep 04, 2025 | Filing ID: 028580

Director MCCORMICK FRANK 🟡 adjusted position in 74.0K shares (1 derivative) of BridgeBio Pharma, Inc. (BBIO) at $53.16 ($5.7M) Transaction Date: Sep 05, 2025 | Filing ID: 000003

Raykov Rosty 🟡 adjusted position in 0 shares (1 derivative) of FENNEC PHARMACEUTICALS INC. (FENC) at $2.45 Transaction Date: Sep 05, 2025 | Filing ID: 023897

New Form 3 - ENANTA PHARMACEUTICALS INC Filed: 2025-09-08 AccNo: 0001062993-25-015415 Size: 19 KB

New Form 3 - ENANTA PHARMACEUTICALS INC Filed: 2025-09-08 AccNo: 0001062993-25-015414 Size: 16 KB

New Form SCHEDULE 13G - vTv Therapeutics Inc. Filed: 2025-09-08 AccNo: 0001641172-25-026895 Size: 26 KB

New Form SCHEDULE 13D/A - Mineralys Therapeutics, Inc. Filed: 2025-09-08 AccNo: 0001415889-25-023895 Size: 19 KB

RA CAPITAL MANAGEMENT, L.P. 🟢 acquired 1.2M shares of Mineralys Therapeutics, Inc. (MLYS) at $25.50 ($30.0M) Transaction Date: Sep 04, 2025 | Filing ID: 023893

Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030

New Form 144 - Warby Parker Inc. Filed: 2025-09-08 AccNo: 0001958244-25-004311 Size: 5 KB

Sable Kyle 🟡 adjusted position in 40.0K shares (1 derivative) of Perimeter Solutions, Inc. (PRM) at $22.05 ($1.2M) Transaction Date: Sep 05, 2025 | Filing ID: 000113